Zhejiang Tailin Bioengineering Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 8.46%

Zhejiang Tailin Bioengineering Co Ltd (300813) has an Asset Resilience Ratio of 8.46% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥80.10 Million

≈ $11.72 Million USD Cash + Short-term Investments

Total Assets

CN¥946.91 Million

≈ $138.56 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2021–2025)

This chart shows how Zhejiang Tailin Bioengineering Co Ltd's Asset Resilience Ratio has changed over time. Check strategic asset allocation of Zhejiang Tailin Bioengineering Co Ltd to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Zhejiang Tailin Bioengineering Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Zhejiang Tailin Bioengineering Co Ltd market cap and net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥80.10 Million	8.46%
Total Liquid Assets	CN¥80.10 Million	8.46%

Asset Resilience Insights

Limited Liquidity: Zhejiang Tailin Bioengineering Co Ltd maintains only 8.46% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Zhejiang Tailin Bioengineering Co Ltd Industry Peers by Asset Resilience Ratio

Compare Zhejiang Tailin Bioengineering Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Cochlear Ltd AU:COH	Medical Devices	9.76%
Novocure Ltd NASDAQ:NVCR	Medical Devices	43.72%
Sinocare Inc SHE:300298	Medical Devices	3.53%
L&C Bio Co. Ltd KQ:290650	Medical Devices	2.14%
Shanghai ZJ Bio-Tech Co. Ltd. A SHG:688317	Medical Devices	10.88%
Bactiguard Holding AB (publ) ST:BACTI-B	Medical Devices	8.12%
Oncosil Medical Ltd AU:OSL	Medical Devices	0.00%
Anteris Technologies Global Corp AU:AVR	Medical Devices	33.27%

Annual Asset Resilience Ratio for Zhejiang Tailin Bioengineering Co Ltd (2021–2025)

The table below shows the annual Asset Resilience Ratio data for Zhejiang Tailin Bioengineering Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	19.13%	CN¥183.51 Million ≈ $26.85 Million	CN¥959.34 Million ≈ $140.38 Million	+16.07pp
2021-12-31	3.06%	CN¥20.05 Million ≈ $2.93 Million	CN¥655.87 Million ≈ $95.97 Million	--

pp = percentage points

About Zhejiang Tailin Bioengineering Co Ltd

SHE:300813 China Medical Devices

Market Cap

$331.83 Million

CN¥2.27 Billion CNY

Market Cap Rank

#14231 Global

#4220 in China

Share Price

CN¥18.71

Change (1 day)

+3.48%

52-Week Range

CN¥17.08 - CN¥40.33

All Time High

CN¥64.43